Brazilian Ministry of Foreign Affairs reported on Saturday, on Twitter, that the federal government is negotiating with the American government to import surplus vaccine doses from the United States.
According to the tweet, the talks started a week ago. “Since March 13, the Brazilian government, through the Itamaraty and the embassy in Washington, in coordination with the Ministry of Health, has been in negotiations with the U.S. government to make it possible for Brazil to import vaccines from the surplus available in the United States,” says the tweet.
The United States, a country that stores 30 million doses of AstraZeneca/Oxford, announced this week that it plans to send about 4 million doses to Mexico and Canada. AstraZeneca/Oxford has not yet been authorized by the American health regulator. According to a report by The New York Times, the American government would be considering the possibility of donating batches of the immunizer to Brazil too.
On Friday, Brazilian Ministry of Health announced the purchase of 138 million doses of COVID-19 vaccine. Of these, 100 million are from Pfizer and 38 million are from Janssen (produced by Johnson & Johnson).
The Government’s schedule predicts that doses will arrive in batches: 13.5 million doses from Pfizer in the second quarter and 86.4 million by September; 16.9 million doses of Janssen are expected to arrive between July and September and 21.1 million between October and December.